OKYO Pharma Announces Public Offering of Ordinary Shares
13 sept. 2023 16h05 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Blue Star Foods Announces Closing of $5 Million Public Offering
11 sept. 2023 16h00 HE
|
Blue Star Foods Corp.
Miami, FL, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), today announced the closing of its previously announced public...
Foremost Lithium Announces Closing of USD $4.0 Million Public Offering and NASDAQ Listing
24 août 2023 13h26 HE
|
Foremost Lithium Resource & Technology Ltd.
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Foremost Lithium Resource & Technology Ltd. (Nasdaq: FMST, FMSTW) (CSE: FAT) ("Foremost Lithium" or the "Company"), an exploration...
CORRECTION -- Nxu Inc. Announces $5 Million Public Offering
09 août 2023 09h30 HE
|
Nxu Inc.
MESA, Ariz., Aug. 09, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Nxu Inc. (NASDAQ: NXU), please note the 3rd paragraph has been changed. The corrected...
Nxu Inc. Announces $5 Million Public Offering
09 août 2023 08h00 HE
|
Nxu Inc.
MESA, Ariz., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Nxu Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a vertically integrated technology company creating energy storage and charging solutions for the...
OKYO Pharma Limited Announces Withdrawal of Public Offering
31 juil. 2023 02h18 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...
OKYO Pharma Announces Proposed Public Offering of Ordinary Shares
28 juil. 2023 17h25 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
25 juil. 2023 08h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care...
Prelude Therapeutics Announces Pricing of Public Offering
18 mai 2023 07h00 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., May 18, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated ("Prelude" or the "Company") (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the...
GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock
17 avr. 2023 09h15 HE
|
GlucoTrack, Inc.
Rutherford, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...